Last reviewed · How we verify

NCT03299634

Oral Mucosal Lesions Among Smokers in an Egyptian Population Study.

Status unknown Last updated 20 October 2017
What this trial tests

trial testing printed questionnaire in Smokers in 840 participants. Status unknown.

Timeline
1 November 2017
Primary endpoint
30 November 2018
1 December 2018

Quick facts

Lead sponsorCairo University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment840
Start date1 November 2017
Primary completion30 November 2018
Estimated completion1 December 2018

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Eligibility, any sex, with Smokers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This cross-sectional study will assess the prevalence of oral changes among smokers in an Egyptian cohort (patients attending to the hospital of Faculty of Dentistry - Cairo University), aiming that this study can serve as a baseline for future studies with the goal of finding ways to improve oral health and increase awareness of the hazards of smoking in Egypt

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of printed questionnaire

Trials testing the same drug.

Other recruiting trials for Smokers

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03299634.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing